Limitations introduced by a low participation rate of SARS-CoV-2 seroprevalence data | Zendy

Olivia Pluss | Zendy; Harlan Campbell | Zendy; Laura Pezzi | Zendy; Ivonne Morales | Zendy; Yannik Roell | Zendy; Talía M. Quandelacy | Zendy; Rahul K. Arora | Zendy; Emily Boucher | Zendy; Molly M. Lamb | Zendy; May C. Chu | Zendy; Till Bärnighausen | Zendy; Thomas Jaenisch | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Limitations introduced by a low participation rate of SARS-CoV-2 seroprevalence data

Author(s) -

Olivia Pluss,

Harlan Campbell,

Laura Pezzi,

Ivonne Morales,

Yannik Roell,

Talía M. Quandelacy,

Rahul K. Arora,

Emily Boucher,

Molly M. Lamb,

May C. Chu,

Till Bärnighausen,

Thomas Jaenisch

Publication year - 2022

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/dyac178

Subject(s) - seroprevalence , interquartile range , representativeness heuristic , medicine , demography , population , statistics , logistic regression , environmental health , mathematics , antibody , serology , sociology , immunology

There has been a large influx of COVID-19 seroprevalence studies, but comparability between the seroprevalence estimates has been an issue because of heterogeneities in testing platforms and study methodology. One potential source of heterogeneity is the response or participation rate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research